EUVIMEDEUVIMED entdecken
Crossref

Anti-Müllerian hormone and HOMA-IR in different phenotypes of polycystic ovary syndrome on insulin resistance

Murat ÖNAL, Halime ÇALI ÖZTÜRK

Anatolian Current Medical Journal · 27.10.2023 · 5 (4) · 376-382

DOI: 10.38053/acmj.1323489 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anatolian Current Medical Journal, online erschienen am 27.10.2023. Verfasst von Murat ÖNAL und 1 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To examine the link between serum anti-mullerian hormone (AMH) levels and homeostatic model assessment of insulin resistance (HOMA-IR) in different phenotypes of polycystic ovary syndrome (PCOS).

Methods

This retrospective study included 120 patients aged 18-30 who visited our polyclinics between June 2021 and December 2022. Patients were divided into four groups based on the Rotterdam criteria for PCOS phenotypes. A control group of 24 individuals was also included. Clinical data, hormonal profiles, and metabolic parameters were obtained from medical records.

Results

There were significant differences in AMH, follicle stimulating hormone (FSH), luteinizing hormone (LH), and high-density lipoprotein (HDL) levels among the PCOS phenotypes and control group. AMH levels were highest in phenotype 1 (oligo/anovulation + hyperandrogenism + polycystic ovaries) and lowest in the control group. FSH were highest in phenotype 4 (oligo/anovulation + polycystic ovaries) and lowest in the control group. LH were highest in phenotype 2 (oligo/anovulation + hyperandrogenism). HOMA-IR was highest in phenotype 1. However, there were no significant differences in AMH or HOMA-IR levels among the PCOS phenotypes.

Conclusion

Our study found hormone level differences among PCOS phenotypes but no significant differences in AMH or HOMA-IR. This suggests AMH may not distinguish between phenotypes and insulin resistance may not differ significantly among phenotypes.

Zitieren

APA

ÖNAL, M., & ÖZTÜRK, H. Ç. (2023). Anti-Müllerian hormone and HOMA-IR in different phenotypes of polycystic ovary syndrome on insulin resistance. Anatolian Current Medical Journal, 5(4), 376-382. https://doi.org/10.38053/acmj.1323489

Vancouver

ÖNAL M, ÖZTÜRK HÇ. Anti-Müllerian hormone and HOMA-IR in different phenotypes of polycystic ovary syndrome on insulin resistance. Anatolian Current Medical Journal. 2023;5(4):376-382. doi:10.38053/acmj.1323489

BibTeX
@article{NAL2023,
  author = {ÖNAL, Murat and ÖZTÜRK, Halime ÇALI},
  title = {Anti-Müllerian hormone and HOMA-IR in different phenotypes of polycystic ovary syndrome on insulin resistance},
  journal = {Anatolian Current Medical Journal},
  year = {2023},
  volume = {5},
  number = {4},
  pages = {376--382},
  doi = {10.38053/acmj.1323489}
}
Kostenlos starten →